Previous 10 | Next 10 |
CANTON, Mass., Aug. 09, 2021 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, to...
CANTON, Mass., Aug. 09, 2021 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, to...
CANTON, Mass., July 02, 2021 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, to...
Inflation is here; and that means these groups ought to be on your radar. The best stocks within every sector now. Over 20 new stocks join our 'best stocks' list this week. For further details see: The Stocks To Focus On Today
The biotech industry saw solid growth last year driven by the demand for therapies to combat COVID-19. But advances in technology helped biotech companies deliver impressive drug candidates for treating other serious ailments too. Consequently, Wall Street analysts expect the biotech industry...
Market leadership by sector and market cap. Sectors remain tilted toward mid-cycle ideas. However, stock-specific ideas are available in every basket. For further details see: The Top Stocks You Can Buy Now
Organogenesis Holdings (NASDAQ: ORGO) , a regenerative health products specialist, shot skyward Thursday thanks to its inclusion on a key stock market index. On Wednesday, after market close, S&P Dow Jones Indices -- operator of the famous S&P family of indexes -- announ...
Gainers: Rezolute (RZLT) +44%, Syros Pharmaceuticals (SYRS) +19%, Lantheus LNTH +17%, Pieris Pharmaceuticals (PIRS) +14%, Organogenesis (ORGO) +10%.Losers: NextGen Healthcare (NXGN) -13%, Protagenic Therapeutics (PTIX) -10%, Kintara Therapeuti...
Organogenesis Holdings (ORGO) is up 11.9% after hours on word that it's moving into the S&P SmallCap 600 index. It's going there to replace Crocs (CROX), which itself is moving up into the S&P MidCap 400 to replace Cantel Medical (CMD). Crocs is 3.5% lower postmarket. Cantel Medical i...
Crocs Set to Join S&P MidCap 400 and Organogenesis to Join S&P SmallCap 600 Crocs Set to Join S&P MidCap 400 and Organogenesis to Join S&P SmallCap 600 PR Newswire NEW YORK , May 26, 2021 /PRNewswire/ -- S&P SmallCap 600 constituent Crocs ...
News, Short Squeeze, Breakout and More Instantly...
Organogenesis Holdings Inc. Company Name:
ORGO Stock Symbol:
NASDAQ Market:
Organogenesis Holdings Inc. Website:
CANTON, Mass., July 15, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, to...
2024-06-28 10:00:07 ET Brooks O'Neil from Lake Street issued a price target of $5.00 for ORGO on 2024-06-28 08:01:00. The adjusted price target was set to $5.00. At the time of the announcement, ORGO was trading at $2.64. ORGO currently trades -43.21% versus its 52 week ...
CANTON, Mass., June 06, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today an...